Law Offices of Thomas J. Lamb

  • About Our Firm
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • Breast Implants
  • Free Case Evaluation
  • FAQs

Synvisc-One Knee Injections Recall Due To Contamination

January 9, 2018 By Law Offices of Thomas J. Lamb, P.A.


Background Information

Sanofi Genzyme, the manufacturer of Synvisc-One Knee Injections, has initiated a voluntary urgent recall of one lot of the injections due to a microbial contamination.

Synvisc-One is a hyaluronic acid gel that is injected into the knee.  It helps treat symptoms of arthritis by cushioning and lubricating the joint, and is typically used in patients with arthritis whose pain is not adequately treated with diet, exercise and over-the-counter pain medication.

A recent article from the Boston Globe states that identification number for the contaminated lot of Synvisc-One is 7RSL021.  According to Sanofi representatives, the contaminated lot contained approximately 18,000 syringes, and originated from the company’s plant in Ridgefield, New Jersey.  12,380 of the contaminated syringes were distributed across the U.S. between October 25, 2017 and November 7, 2017, and are now being recalled.
 


Synvisc-One

Free Case Evaluation

Strictly Confidential, No Obligation.


 

Side Effects

While the side effects experienced by those injected with this contaminated lot of Synvisc-One are similar to the known potential side effects of the injection, there has been an “unexpected increase in the number of labelled adverse events received from the U.S. market,” according to Sanofi spokesperson Heather Guzzi.  She did not specify which adverse events were most common among those injected with the contaminated lot, but did state that no deaths had taken place as of December 12, 2017.

Sanofi warns that infection may result from contaminated injections, and side effects may include:

  • Pain in the knee
  • Swelling
  • Heat
  • Redness
  • Fluid build-up in or around the knee
  • Difficulty walking

If you were hospitalized due to any of these symptoms after receiving a Synvisc-One knee injection, we encourage you to complete a Free Case Evaluation.

We will continue to monitor the medical and legal news concerning Synvisc-One injections, and report on any significant developments as we become aware of them.

 

Written by: Heather Helmendach, Legal Assistant 
Law Offices of Thomas J. Lamb, P.A.

 

Drug Injury Watch: Side Effects News & Reports

Drug Injury Law: Medical & Legal Information

 

 

 

Filed Under: Unsafe Drugs Tagged With: contamination, knee injection recall, recall, Sanofi Genzyme, Synvisc-One Knee Injections

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.